|
Catalog Number VS-404 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Pulmonary Embolism (1498); Thrombosis/Thrombus (4440)
|
Event Date 10/19/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Patient had a venaseal procedure on her right great saphenous vein (gsv) on (b)(6) 2023 and left gsv on (b)(6) 2023.The ifu (instruction for use) was followed during preparation, procedure, post-procedure.A guidewire was used for the insertion of the catheter.Tumescent infiltration was not utilized.Local anesthesia was used.Transducer compression was used.Procedure was completed normally.Patient no showed for her ultrasound and office visit post op and called the office stating she was covid positive.She is currently an inpatient with pulmonary embolism (pe)/deep vein thrombosis (dvt).Physician¿s office does not think it has anything to do with the venaseal procedure and thinks it has to do with her covid diagnosis.
|
|
Manufacturer Narrative
|
Additional information: date of onset symptoms was (b)(6) 2023.There were no challenges or deviations related to location of catheter tip prior to initial delivery of adhesive and the catheter tip was positioned 5cm caudal to sfj.Patient cancelled appointment on (b)(6)2023 due to testing positive for covid.Patient was admitted on (b)(6) 2023 and was put on xarelto.Patient did not attentd follow up appointments on (b)(6) 2023 and did not attend both appointments.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|